An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19.

ABSTRACT: The outbreak of COVID-19 was recognized in December 2019 in China and as of October5^th, the pandemic was swept through 216 countries and infected around 34,824,108 individuals, thus posing an unprecedented threat to world's health and economy. Several researchers reported that, a significant mutation in membrane proteins and receptor binding sites of preceding severe acute respiratory syndrome coronavirus (SARS-CoV) to turned as novel SARS-CoV-2 virus and disease was named as COVID-19 (Coronavirus disease 2019). Unfortunately, there is no specific treatment available for COVID-19 patients. The lessons learned from the past management of SARS-CoV and other pandemics, have provided some insights to treat COVID-19. Currently, therapies like anti-viral treatment, immunomodulatory ag

SUBMITTER: Rao GSNK 

PROVIDER: S-EPMC8498785 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature